Entity Common Stock, Shares Outstanding of CRESCENT BIOPHARMA, INC. from 08 May 2014 to 23 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CRESCENT BIOPHARMA, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 08 May 2014 to 23 Feb 2026.
  • CRESCENT BIOPHARMA, INC. Entity Common Stock, Shares Outstanding for the quarter ending 23 Feb 2026 was 27,556,767, a 57% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 27,556,767 -36,975,324 -57% 23 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 13,892,516 -50,591,442 -78% 03 Nov 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 13,892,562 -50,591,396 -78% 25 Jul 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 64,532,091 +81,706 +0.13% 12 May 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 64,513,862 07 Feb 2025 10-K 13 Feb 2025 2024 FY
Q3 2024 64,483,958 +90,664 +0.14% 13 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 64,483,958 +167,690 +0.26% 07 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 64,450,385 +205,161 +0.32% 25 Mar 2024 10-K 27 Mar 2024 2023 FY
Q3 2023 64,393,294 +11,969,350 +23% 01 Nov 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 64,316,268 +11,892,324 +23% 31 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 64,245,224 +11,852,780 +23% 27 Mar 2023 10-K 29 Mar 2023 2022 FY
Q3 2022 52,423,944 +685,050 +1.3% 07 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 52,423,944 +884,934 +1.7% 01 Aug 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 52,392,444 +853,434 +1.7% 27 Apr 2022 10-Q 28 Apr 2022 2022 Q1
Q3 2021 51,738,894 +3,910,063 +8.2% 29 Oct 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 51,539,010 +3,814,279 +8% 03 Aug 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 51,539,010 +7,956,031 +18% 30 Apr 2021 10-Q 03 May 2021 2021 Q1
Q3 2020 47,828,831 +4,468,882 +10% 04 Nov 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 47,724,731 +4,531,541 +10% 30 Jul 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 43,582,979 +401,810 +0.93% 29 Apr 2020 10-Q 01 May 2020 2020 Q1
Q3 2019 43,359,949 +222,722 +0.52% 04 Nov 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 43,193,190 +135,923 +0.32% 30 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 43,181,169 +684,014 +1.6% 30 Apr 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 43,137,227 +8,799,428 +26% 31 Oct 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 43,057,267 +10,334,222 +32% 08 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 42,497,155 +19,167,255 +82% 01 May 2018 10-Q 03 May 2018 2018 Q1
Q3 2017 34,337,799 +11,272,668 +49% 07 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 32,723,045 +9,666,768 +42% 02 Aug 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 23,329,900 +3,979,578 +21% 27 Feb 2017 10-K 01 Mar 2017 2016 FY
Q3 2016 23,065,131 +4,026,964 +21% 03 Nov 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 23,056,277 +4,037,144 +21% 03 Aug 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 19,350,322 +355,484 +1.9% 02 May 2016 10-Q 04 May 2016 2016 Q1
Q3 2015 19,038,167 +143,425 +0.76% 10 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 19,019,133 +125,669 +0.66% 04 Aug 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 18,994,838 +201,374 +1.1% 10 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 18,894,742 29 Oct 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 18,893,464 29 Jul 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 18,793,464 08 May 2014 10-Q 09 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.